| Nucleolin | |
|---|---|
| Gene | [NCL](/genes/ncl) |
| UniProt | P19367 |
| PDB Structures | 2K3E, 2JSS |
| Molecular Weight | 76 kDa (primary isoform) |
| Subcellular Localization | Nucleolus, Nucleus, Cytoplasm, Cell Surface |
| Protein Family | Nucleolin Family |
| Associated Diseases | ALS, Alzheimer, Autoimmune, Cancer |
| KG Connections | 19 edges |
Nucleolin Protein
Introduction
Nucleolin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
flowchart TD
NUCLEOLIN["NUCLEOLIN"] -->|"involved in"| Chromatin_Remodeling["Chromatin Remodeling"]
NUCLEOLIN["NUCLEOLIN"] -->|"regulates"| Gene_Expression["Gene Expression"]
NUCLEOLIN["NUCLEOLIN"] -->|"modulates"| Cell_Proliferation["Cell Proliferation"]
NUCLEOLIN["NUCLEOLIN"] -->|"involved in"| DNA_Replication["DNA Replication"]
NUCLEOLIN["NUCLEOLIN"] -->|"involved in"| Apoptosis["Apoptosis"]
NUCLEOLIN["NUCLEOLIN"] -->|"implicated in"| DISEASES["DISEASES"]
NUCLEOLIN["NUCLEOLIN"] -->|"biomarker for"| Autoimmune["Autoimmune"]
NUCLEOLIN["NUCLEOLIN"] -->|"biomarker for"| ALS["ALS"]
NUCLEOLIN["NUCLEOLIN"] -->|"biomarker for"| Alzheimer["Alzheimer"]
NUCLEOLIN["NUCLEOLIN"] -->|"biomarker for"| Cancer["Cancer"]
NUCLEOLIN["NUCLEOLIN"] -->|"inhibits"| Als["Als"]
NUCLEOLIN["NUCLEOLIN"] -->|"inhibits"| SRPK1["SRPK1"]
NUCLEOLIN["NUCLEOLIN"] -->|"inhibits"| TAF15["TAF15"]
NUCLEOLIN["NUCLEOLIN"] -->|"inhibits"| HNRPU["HNRPU"]
style NUCLEOLIN fill:#4fc3f7,stroke:#333,color:#000Nucleolin is one of the most abundant nucleolar proteins, constituting up to 10% of nucleolar protein mass. It is a multifunctional protein involved in ribosome biogenesis, chromatin organization, DNA replication, and RNA metabolism. Nucleolin is also expressed on the cell surface, where it serves as a receptor for various molecules.
Structure
Nucleolin has a modular architecture:
-
N-terminal Domain: Acidic stretches (aspartate/glutamate-rich) for protein-protein interactions
-
Central Region: Contains four RNA recognition motifs (RRMs)
-
C-terminal Domain: Arginine-glycine-glycine (RGG) repeats for RNA binding
-
Nuclear Localization Signals (NLS): Multiple NLS sequences
-
Cell Surface Targeting Domain: C-terminal region for membrane localization
The protein can form homodimers and interact with numerous partners.
Normal Function
Ribosome Biogenesis
-
Binds to rDNA promoter and enhances transcription by RNA polymerase I
-
Processes pre-rRNA (18S, 28S rRNA)
-
Assembles ribosomal subunits
-
Transports ribosomal proteins to nucleolus
Chromatin Organization
-
Binds to histone H1
-
Modulates chromatin condensation
-
Participates in DNA replication origin firing
DNA Repair
-
Associates with DNA damage response proteins
-
Facilitates repair of double-strand breaks
-
Regulates p53 stability
RNA Metabolism
-
Binds to various RNA species
-
Regulates mRNA stability and translation
-
Processes snRNA and microRNA
Cell Surface Functions
-
Acts as a receptor for growth factors (e.g., lactoferrin)
-
Mediates endocytosis
-
Binds to pathogens (e.g., HIV-1)
Role in Disease
Neurodegeneration
Nucleolin alterations in neurodegenerative diseases:
-
Alzheimer’s Disease: Colocalizes with amyloid-beta plaques; may influence APP processing and Aβ toxicity
-
Parkinson’s Disease: Involved in alpha-synuclein aggregation; nucleolin mislocalization in PD brains
-
ALS: TDP-43 pathology disrupts nucleolin localization; some NCL variants associated with ALS risk
Cancer
Nucleolin is a therapeutic target in cancer:
-
Overexpressed in proliferating cancer cells
-
Promotes angiogenesis via VEGF
-
Cell surface nucleolin targeted by anticancer drugs (e.g., AS1411)
Ribosomopathies
Dysregulated nucleolin function contributes to:
-
Diamond-Blackfan anemia
-
Other ribosomal assembly disorders
Therapeutic Targeting
Nucleolin as a therapeutic target:
-
AS1411: Antimetastatic oligonucleotide that targets cell surface nucleolin
-
Nucleolin-targeted nanoparticles: Drug delivery vehicles
-
Small molecule inhibitors: Under development
Key Publications
-
Ginisty H, et al. (1999). “Structure and functions of nucleolin.” J Cell Sci 112(Pt 6):761-772. 1Structure and functions of nucleolinOpen reference(https://pubmed.ncbi.nlm.nih.gov/10051131/)
-
Srivastava M, et al. (2009). “Nucleolin: a multi-tasking protein.” J Cell Physiol 226(7):1792-1801. 2Nucleolin: a multi-tasking protein with key roles in cell physiologyOpen reference(https://pubmed.ncbi.nlm.nih.gov/21337556/)
-
Maras B, et al. (2020). “Nucleolin in neurodegeneration.” Neurosci Lett 715:134605. 3Nucleolin in neurodegenerationOpen reference(https://pubmed.ncbi.nlm.nih.gov/31759919/)
Related Pages
See Also
-
Proteins/Nucleolin — This page
Background
The study of Nucleolin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
-
PubMed - Biomedical literature
-
Alzheimer’s Disease Neuroimaging Initiative - Research data
-
Allen Brain Atlas - Brain gene expression data
References
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.